Novartis Gets Immune -Cell Cancer Therapy in UPenn Pact Businessweek Novartis AG (NOVN) will fund a $20 million research center at the University of Pennsylvania in a deal in which the drugmaker gains technology that uses manipulated immune – system cells to fight cancer. Under the pact, the Philadelphia school will … Novartis and Penn Unite on New Anticancer Path New York Times University of Pennsylvania and Novartis Form Alliance to Expand Use of ..
View original post here:
Novartis Gets Immune-Cell Cancer Therapy in UPenn Pact – Businessweek
Click here for more interesting articles
Tags: Immune support